Effect of budesonide nebulizer on reducing BPD
Phase 3
Recruiting
- Conditions
- Bronchopulmonary dysplasia.Bronchopulmonary dysplasia originating in the perinatal periodP27.1
- Registration Number
- IRCT20230823059227N1
- Lead Sponsor
- Karaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Premature neonates between 24 and 32 weeks
Exclusion Criteria
Weight Less than 500 grams
Neonate with fatal congenital abnormalities or disorders and congenital heart and lung diseases
Pneumothorax
Severe sepsis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Broncopulmonary dysplasia. Timepoint: Daily. Method of measurement: The need for supplemental oxygen at 28 days of age.;Duration of hospitalization. Timepoint: Days of hospital stay. Method of measurement: Time between admission and discharge.;Duration of need for oxygen. Timepoint: Daily. Method of measurement: Days count before O2 discontinue.
- Secondary Outcome Measures
Name Time Method The duration of the treatment. Timepoint: Discharge Time. Method of measurement: The number of days of hospitalization records.